宁虫素对蔬菜、水稻害虫的毒力及药效特性研究

本研究了复方生物农药宁虫素对蔬菜、水稻害虫的毒力及药效特性,结果表明,该药集速效性、特效性于一体,对蚜虫、褐飞虱的毒力分别为：0.63ppm和2.00ppm。田间试验表明,宁虫素可有效地控制蔬菜蚜虫、小菜蛾、菜青虫、稻飞虱等的危害,防效显。田间使用宁虫素后,平均蛛虱比明显优于噻嗪酮和吡虫啉,生态安全性好。     

三峡水库社区渔业浅析

文章考察了国内外社区渔业的发展概况, 并基于三峡水库的实际情况开展了渔业社区的构建和运行试验, 结果显示, 社区渔业在三峡库湾实现了生态效益、经济效益和社会效益, 具有综合效应, 将是养护三峡渔业资源、开展渔业生产的一种重要组织方式, 可确保三峡渔业的可持续发展。同时, 通过实践还确认了三峡水库实施社区渔业存在现实的困难, 渔业社区的构建和运营在准入制度、管理体制等诸多方面存在问题,三峡水库发展社区渔业需要政策引导和资金扶持, 同时需要严格的管理制度确保良好的从业环境。       

黔产毛萼香茶菜二萜成分

综合利用硅胶、凝胶、MCI等柱层析方法从毛萼香茶菜中进行分离、纯化到10个二萜化合物,结合MS、1H NMR、13C NMR和相关文献资料分别鉴定为6-乙酰基-毛萼晶B(1)、毛萼晶O(2)、12-hydroxydehydro-abietic acid(3)、Neorabdosin(4)、毛萼晶D(5)、毛萼晶E(6)、毛萼晶B(7)、毛萼晶N(8)、Coetsoidin A(9)、毛萼晶L(10)。其中化合物1为新天然产物,3为首次从该植物中分离。     

核酸适配体介导的多药耐药性肿瘤的治疗

化疗是目前肿瘤治疗最常见的方法。然而,肿瘤细胞的多药耐药（multidrug resistance,MDR）常导致临床化疗失败及患者的死亡。因此,干预和逆转肿瘤多药耐药,提高化疗效果,对于肿瘤的治疗具有重要的意义。核酸适配体是一种短的单链寡核苷酸,通过折叠形成特定空间结构从而与靶标特异性结合。靶向肿瘤的核酸适配体可以选择性地将治疗性物质（抗癌药物,siRNA,miRNA）和药物载体递送至肿瘤中,对肿瘤进行靶向杀伤。利用核酸适配体靶向多药耐药性肿瘤,能够特异性干预甚至逆转肿瘤的多药耐药性。本文概述了核酸适配体介导的干预与逆转肿瘤多药耐药性的研究进展。     

mTORC2 is a tyrosine kinase

The mammalian target of rapamycin (mTOR), a protein kinase, is the centre of huge attention due to its importance in intracellular signaling and in health and disease. In their recent study, Yin et al. show that mTOR can regulate signaling through the insulin-like growth factor 1 receptor and that it possesses a new enzymatic activity — the ability to phosphorylate proteins on tyrosine residues.mTOR is a large, multi-domain protein; its catalytic domain resembles that of lipid kinases such as phosphoinositide 3-kinase (PI 3-kinase), but mTOR actually has protein kinase activity, adding phosphate groups to serine or threonine residues in a growing catalog of substrates, many of which are involved in anabolic pathways.mTOR binds to several protein partners in the cell to form two distinct types of complexes, termed mTOR complexes 1 and 2 (mTORC1/2¹). These differ in their protein components, substrate specificity and regulation. For example, mTORC1 is activated by amino acids, and by hormones and growth factors. mTORC1 contains a protein termed Raptor which allows it to phosphorylate substrates such as the ribosomal protein S6 kinases (S6Ks), and this effect is blocked by rapamycin.mTORC2 contains Rictor in place of Raptor and therefore phosphorylates a distinct set of substrates. These include regulatory (so-called ''hydrophobic'') sites in a family of protein kinases which include Akt, also called protein kinase B (PKB). Rapamycin does not directly inhibit mTORC2 function, but can impair it after longer-term treatment². The regulation of mTORC2 activity remains poorly understood.mTOR complexes play multifaceted roles in insulin signaling. For example, Akt plays key roles in insulin signaling, mediating the regulation of various proteins involved in the effects of this hormone on metabolism, e.g., glucose transport. Akt signaling indirectly activates mTORC1. In turn, mTORC1 regulates key anabolic processes including protein, lipid and ribosome synthesis. However, mTORC1 can, via the S6Ks, inhibit insulin signaling. This involves the phosphorylation of insulin receptor substrates 1 or 2 (IRS1/2), a crucial link between insulin (and related) receptors and downstream signalling protein, e.g., Akt.The receptors for insulin (InsR) and insulin-like growth factor I (IGF-IR) are ligand-activated tyrosine kinases, which undergo autophosphorylation allowing them to phosphorylate additional proteins such as IRS1. In turn, phosphorylated IRS1 binds PI 3-kinase; this leads to enhanced production of phosphatidylinositol 3,4,5-trisphosphate, PIP₃, and to activation of Akt.Yin et al.³ found that rapamycin led to increased phosphorylation of InsR and IGF-IR at key autophosphorylation sites, reflecting increased kinase activity of these receptors.Knockdown of mTOR or Rictor, or treatment of cells with an inhibitor of mTOR kinase activity, Torin 2, decreased the rapamycin-induced phosphorylation of InsR or IGF-IR, while Raptor knockdown had the converse effect. This indicates the effect requires mTORC2; indeed, the authors show that mTORC2 binds to these receptors, apparently via IRS1/2. However, mTORC2 does not appear to directly phosphorylate IRS1/2. One possible way in which mTORC2 increases tyrosine phosphorylation of InsR or IGF-IR is by stimulating the kinase activity of the receptors which then catalyse the phosphorylation of the receptors on tyrosine. The authors ruled this out, by using kinase-dead versions of the receptors or mTOR. Therefore, mTORC2 promotes the tyrosine phosphorylation of InsR/IGF-1R, which is required for downstream signaling from these receptors. While these authors clearly show that rapamycin causes increased phosphorylation of the mTORC2 substrate AKT, earlier studies showed that, at similar time points of treatment in the same cell-type, rapamycin inhibited AKT phosphorylation indicating interference with mTORC2 function². It is not clear how rapamycin promotes mTORC2 function under the conditions used in this study. Another study⁴ found that mTORC2 promotes degradation of IRS1, suggesting, in contrast to the conclusions of Yin et al., that mTORC2 can promote insulin resistance. These and other data suggest that the web of interactions between these signaling components is indeed very complex (Figure 1).Open in a separate windowFigure 1Summary of the signalling connections discussed here, including the new link described by Yin et al.³ between mTORC2 and the insulin/IGF-1 receptors. Phosphorylation sites are shown schematically (not all are indicated) as ''P'' in a yellow background; Y, S and T indicate tyrosine, serine and threonine respectively. Green and red arrows show activating and inhibitory phosphorylation events respectively. The gray arrow and ''?'' indicate potential further tyrosine phosphorylation events catalysed by mTORC2. Solid arrows show direct phosphorylation events; dashed lines are indirect signalling links.mTOR has previously only been reported to act on serine or threonine residues; the present report shows that mTOR can efficiently phosphorylate tyrosines in vitro using either recombinant InsR or peptides as substrate. These data reveal that mTORC2 function is a ''dual-specificity'' protein kinase phosphorylating tyrosine as well as serine/threonine sites. Interestingly, mTORC1 was unable to phosphorylate tyrosines.Does the mTORC2-stimulated phosphorylation of the InsR/IGF-1R play a role in the actions of the ligands for these receptors? To test this, the authors examined the Rictor knockdown on HepG2 cell proliferation. While this had no effect in the absence of insulin or IGF-1, depletion of Rictor did inhibit proliferation in IGF-1- or insulin-stimulated conditions. Rictor overexpression increased proliferation, an effect that requires the activity of the InsR/IGF-1R.What are the main implications of these data? First, rapamycin may actually promote signaling from the InsR/IGF-1R through mTORC2 (as well as via Grb10, a target for mTORC1 itself^5,6) both by the mechanism delineated here and by abrogating the feedback loop from mTORC1 via the S6Ks to IRS1. Second, combining Ins/IGF-1R receptor inhibitors with mTOR inhibitors may be a more effective anti-cancer treatment than inhibiting the individual pathways. Third, mTORC2 may phosphorylate additional, so far unidentified proteins on tyrosine, adding to the growing repertoire of mTOR substrates.     

癌组织中的遗传不稳定性的RAPD分析(简报)

肿瘤仍然是导致人类死亡的重要原因,由于缺乏深刻了解癌症的发生机制,尽管在过去25年中肿瘤的诊断和治疗都取得很大的进展,但肿瘤病人的存活率并没有显著的提高。目前有很多癌基因和抑癌基因如P16、P53、P73、ras、DCC和RB等     

大鼠脊髓细胞膜胰岛素受体的结合特性

大鼠脊髓细胞膜胰岛素受体的结合特性朱尚权,徐明华,张新堂,叶莺（中国科学院上海生物化学研究所,２０００３１）姜新建,林淑琼（上海市第一人民医院康复科,２０００８５）关键词胰岛素受体,脊髓细胞膜免疫组织化学、放射免疫自显影和放射受体测定技术已证明脑各区...     

福建泰宁野生铁皮石斛种群的ISSR亲缘关系分析

为了解铁皮石斛(Dendrobium officinale)种质间的亲缘关系,利用ISSR技术对34份铁皮石斛种质资源进行亲缘关系和遗传多样性分析。结果表明,9条ISSR引物在34份种质中共扩增出78条带,多态位点百分率达100%。UPGMA聚类分析表明,种质的相似系数为0.61~0.92,在相似系数0.626处,福建省泰宁的野生铁皮石斛与栽培铁皮石斛分为两大类。泰宁野生铁皮石斛种群的Nei’s基因多样性(H)和遗传分化系数(Gst)分别为0.3111和0.4609,均高于栽培种群(0.3056和0.4204),表明泰宁野生铁皮石斛具有较丰富的多样性和较高的种群分化系数。AMOVA分析表明,铁皮石斛种群内变异指数为74%,种群间变异指数为26%,表明不同种群间可能存在基因交流。这些为不同地域的野生铁皮石斛资源的有效保护及利用提供理论依据及技术参考。